Stem cell showdown: can early transplant beat standard meds for scleroderma?

NCT ID NCT04464434

First seen Mar 29, 2026 · Last updated Apr 29, 2026 · Updated 3 times

Summary

This study tested whether using a stem cell transplant right away is better than starting with standard immune-suppressing drugs for people with early, severe scleroderma. Sixty adults with the disease were randomly assigned to one of two treatment strategies. The goal was to see which approach better prevents organ damage and improves survival.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SYSTEMIC SCLEROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Amsterdam Rheumatology Centre

    Amsterdam, Netherlands

  • Gaetano Pini-CTO

    Milan, Italy

  • Ospedale San Raffaele

    Milan, Italy

  • Radboudumc Nijmegen

    Nijmegen, Netherlands

  • Sheffield Teaching Hospitals NHS Foundation Trust

    Sheffield, United Kingdom

  • University Hospital Rome

    Roma, Italy

  • University Medical Centre Leiden

    Leiden, Netherlands

  • University Medical Centre Utrecht

    Utrecht, Netherlands

Conditions

Explore the condition pages connected to this study.